Based on the TOPAZ-1 study, do you routinely include durvalumab in first line treatment of advanced bile duct cancer?  

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at St Jude Heritage Medical Group
Is it FDA approved yet?
Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
The FDA granted durvalumab an orphan drug designat...
Sign in or Register to read more